Pharmaxis, Ltd
- Biotech or pharma, therapeutic R&D
Pharmaxis is a well funded Australian Biotech company with a portfolio of products for inflammation and fibrosis at pre clinical, phase 1, 2,3 and approved in US and EU markets. Pharmaxis is listed on the Australian Securities Exchange (symbol ASX:PXS).
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}